Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "DNA or cellular enzymes" refers generically to either the entire DNA molecule within cells or to the wide spectrum of enzymes functioning within cells. DNA serves as the genetic material and is the target of various anticancer and antiviral drugs via mechanisms such as intercalation, alkylation, or inhibition of DNA-processing enzymes like topoisomerases. "Cellular enzymes" refers to all enzymes catalyzing diverse biochemical reactions, classified into oxidoreductases, transferases, hydrolases, lyases, isomerases, ligases, and translocases[2][4][6][8]. Both categories are implicated in numerous diseases and serve as the basis for a breadth of therapeutic targets, but referencing them as a single entity is overly broad and non-specific for most drug discovery or clinical applications.
Intercalation, Alkylation and DNA crosslinking, Chain termination, Topoisomerase poisoning, Enzymatic inhibition or activation, Covalent modification, Epigenetic regulation
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA or cellular enzymes.